Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Darragh Duffy

Showing results (111-120 of 182) with videos related to

Pageof 19
Sort By:
Clinical Pharmacology and Therapeutics|October 5, 2023
Neutralizing Antibody Levels as a Correlate of Protection Against SARS-CoV-2 Infection: A Modeling AnalysisGuillaume Lingas, Delphine Planas, Hélène Péré, et al.
The Journal of Experimental Medicine|April 14, 2025
Enhanced TLR7-dependent production of type I interferon by pDCs underlies pandemic chilblainsFanny Saidoune, Danyel Lee, Jeremy Di Domizio, et al.
Rheumatology (Oxford, England)|May 24, 2025
Myositis-specific autoantibody subtypes are associated with response to Janus kinase inhibitors in patients with juvenile dermatomyositisBrigitte Bader-Meunier, Thomas R J Moreau, Florence Aeschlimann, et al.
Journal of Autoimmunity|October 10, 2019
Risk factors associated with myasthenia gravis in thymoma patients: The potential role of thymic germinal centersClaire Mj Lefeuvre, Cloé A Payet, Odessa-Maud Fayet, et al.
Annals of Intensive Care|July 17, 2021
Platelet activation in critically ill COVID-19 patientsNader Yatim, Jeremy Boussier, Richard Chocron, et al.
Nature Immunology|September 2, 2021
Distinct systemic and mucosal immune responses during acute SARS-CoV-2 infectionNikaïa Smith, Pedro Goncalves, Bruno Charbit, et al.
Nature Immunology|February 16, 2026
Demographic and genetic factors shape the epitope specificity of the human antibody repertoire against virusesAxel Olin, Christian Pou, Anthony Jaquaniello, et al.
Brain : a Journal of Neurology|May 10, 2018
JAK inhibitor improves type I interferon induced damage: proof of concept in dermatomyositisLeandro Ladislau, Xavier Suárez-Calvet, Ségolène Toquet, et al.
Gut|April 5, 2018
Development and clinical validation of the Genedrive point-of-care test for qualitative detection of hepatitis C virusAlba Llibre, Yusuke Shimakawa, Estelle Mottez, et al.
Clinical Immunology (Orlando, Fla.)|September 26, 2017
Standardized whole blood stimulation improves immunomonitoring of induced immune responses in multi-center studyDarragh Duffy, Vincent Rouilly, Cecile Braudeau, et al.
Pageof 19

Showing results (111-120 of 182) with videos related to

Sort By:
Pageof 19
Clinical Pharmacology and Therapeutics|October 5, 2023
Neutralizing Antibody Levels as a Correlate of Protection Against SARS-CoV-2 Infection: A Modeling AnalysisGuillaume Lingas, Delphine Planas, Hélène Péré, et al.
The Journal of Experimental Medicine|April 14, 2025
Enhanced TLR7-dependent production of type I interferon by pDCs underlies pandemic chilblainsFanny Saidoune, Danyel Lee, Jeremy Di Domizio, et al.
Rheumatology (Oxford, England)|May 24, 2025
Myositis-specific autoantibody subtypes are associated with response to Janus kinase inhibitors in patients with juvenile dermatomyositisBrigitte Bader-Meunier, Thomas R J Moreau, Florence Aeschlimann, et al.
Journal of Autoimmunity|October 10, 2019
Risk factors associated with myasthenia gravis in thymoma patients: The potential role of thymic germinal centersClaire Mj Lefeuvre, Cloé A Payet, Odessa-Maud Fayet, et al.
Annals of Intensive Care|July 17, 2021
Platelet activation in critically ill COVID-19 patientsNader Yatim, Jeremy Boussier, Richard Chocron, et al.
Nature Immunology|September 2, 2021
Distinct systemic and mucosal immune responses during acute SARS-CoV-2 infectionNikaïa Smith, Pedro Goncalves, Bruno Charbit, et al.
Nature Immunology|February 16, 2026
Demographic and genetic factors shape the epitope specificity of the human antibody repertoire against virusesAxel Olin, Christian Pou, Anthony Jaquaniello, et al.
Brain : a Journal of Neurology|May 10, 2018
JAK inhibitor improves type I interferon induced damage: proof of concept in dermatomyositisLeandro Ladislau, Xavier Suárez-Calvet, Ségolène Toquet, et al.
Gut|April 5, 2018
Development and clinical validation of the Genedrive point-of-care test for qualitative detection of hepatitis C virusAlba Llibre, Yusuke Shimakawa, Estelle Mottez, et al.
Clinical Immunology (Orlando, Fla.)|September 26, 2017
Standardized whole blood stimulation improves immunomonitoring of induced immune responses in multi-center studyDarragh Duffy, Vincent Rouilly, Cecile Braudeau, et al.
Pageof 19